Mexico granted market approval to Apricus Biosciences Inc.'s (Nasdaq: APRI) erectile dysfunction treatment Vitaros sending the stock price soaring $1.35 to close at $2.86.
Market approval in Mexico granted to Apricus Biosciences
January 18, 2017 at 15:35 PM EST
